What is Kura Oncology's total equity?

Kura Oncology (KURA) reported total equity of $107.88M in Q1 2026.

How has Kura Oncology's total equity changed year-over-year?

Kura Oncology's total equity decreased by 70.4% year-over-year, from $364.41M to $107.88M.

What is the long-term trend for Kura Oncology's total equity?

Over 5 years (2020 to 2025), Kura Oncology's total equity has grown at a -22.2% compound annual growth rate (CAGR), from $610.91M to $174.14M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Kura Oncology KURA Total Equity

Total Equity at other companies

AmgenAMGN

$9.19B+48.1%

ExelixisEXEL

$1.94B-9.2%

Syndax PharmaceuticalsSNDX

$41.62M-80.6%

AbbVieABBV

-$6.66B-569%

Corvus PharmaceuticalsCRVS

$240.68M+388%

Johnson & JohnsonJNJ

——

Other financials

Income statement

See full

Revenue$18.3M+29.5%

Gross profit$18.0M—

Operating income-$78.8M-21.8%

Net income-$73.3M-27.7%

EPS (diluted)-$0.83-25.8%

Balance sheet

See full

Cash & equivalents$39.1M-23.8%

Total debt$24.3M+25.4%

Total assets$652.6M-12.3%

Cash flow

See full

Operating cash flow-$85.9M-19.4%

CapEx$128.0K-56.2%

Free cash flow-$86.0M-19.1%

Valuation

See full

Market cap$942.78M+86.2%

Enterprise value$927.97M+95.5%

P/S13.2×+3.9×

Profitability

See full

Operating margin-443.5%+103pp

Net margin-411.2%+125pp

FCF margin130.6%+74.1pp

Returns & leverage

See full

Return on equity-124.7%-252pp

Debt / equity0.2×+0.2×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by Kura Oncology in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kura Oncology's total equity?: Kura Oncology (KURA) reported total equity of $107.88M in Q1 2026.
How has Kura Oncology's total equity changed year-over-year?: Kura Oncology's total equity decreased by 70.4% year-over-year, from $364.41M to $107.88M.
What is the long-term trend for Kura Oncology's total equity?: Over 5 years (2020 to 2025), Kura Oncology's total equity has grown at a -22.2% compound annual growth rate (CAGR), from $610.91M to $174.14M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.